Functional Characteristics of C-terminal Lysine to Cysteine Mutant Form of CTLA-4Ig.
- Author:
Bongi KIM
1
;
Jun Seop SHIN
;
Chung Gyu PARK
Author Information
- Publication Type:In Vitro ; Original Article
- Keywords: Mutation; CTLA-4Ig; Costimulation; T cell
- MeSH: Animals; Blotting, Western; Cell Proliferation; Cricetinae; Cricetulus; Cysteine; DNA; Drug Delivery Systems; Electroporation; Female; Graft Survival; Islets of Langerhans; Islets of Langerhans Transplantation; Liposomes; Lymphocyte Culture Test, Mixed; Lysine; Ovary; Polymerase Chain Reaction; Proteins; Transplants
- From:Immune Network 2013;13(1):16-24
- CountryRepublic of Korea
- Language:English
- Abstract: CTLA-4Ig is regarded as an inhibitory agent of the T cell proliferation via blocking the costimulatory signal which is essential for full T cell activation. To improve applicability, we developed the CTLA-4Ig-CTKC in which the c-terminal lysine had been replaced by cysteine through single amino acid change. The single amino acid mutation of c-terminus of CTLA-4Ig was performed by PCR and was checked by in vitro transcription and translation. DNA construct of mutant form was transfected to Chinese hamster ovary (CHO) cells by electroporation. The purified proteins were confirmed by Western blot and B7-1 binding assay for their binding ability. The suppressive capacity of CTLA-4Ig-CTKC was evaluated by the mixed lymphocyte reaction (MLR) and in the allogeneic pancreatic islet transplantation model. CTLA-4Ig-CTKC maintained binding ability to B7-1 molecule and effectively inhibits T cell proliferation in MLR. In the murine allogeneic pancreatic islet transplantation, short-term treatment of CTLA-4Ig-CTKC prolonged the graft survival over 100 days. CTLA-4Ig-CTKC effectively inhibits immune response both in MLR and in allogeneic islet transplantation model, indicating that single amino acid mutation does not affect the inhibitory function of CTLA-4Ig. CTLA-4Ig-CTKC can be used in vehicle-mediated drug delivery system such as liposome conjugation.
